nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucytosine—Proctocolitis—Irinotecan—colon cancer	0.0439	0.0587	CcSEcCtD
Flucytosine—Colitis ulcerative—Irinotecan—colon cancer	0.0439	0.0587	CcSEcCtD
Flucytosine—DNMT1—Vinblastine—Vincristine—colon cancer	0.0438	1	CbGdCrCtD
Flucytosine—DNMT1—embryo—colon cancer	0.0419	0.2	CbGeAlD
Flucytosine—DNMT1—epithelium—colon cancer	0.0342	0.163	CbGeAlD
Flucytosine—DNMT1—lymphoid tissue—colon cancer	0.0263	0.126	CbGeAlD
Flucytosine—DNMT1—digestive system—colon cancer	0.026	0.124	CbGeAlD
Flucytosine—DNMT1—bone marrow—colon cancer	0.024	0.114	CbGeAlD
Flucytosine—Parkinsonism—Fluorouracil—colon cancer	0.0233	0.0313	CcSEcCtD
Flucytosine—DNMT1—vagina—colon cancer	0.0229	0.11	CbGeAlD
Flucytosine—Azotaemia—Vincristine—colon cancer	0.0214	0.0286	CcSEcCtD
Flucytosine—DNMT1—liver—colon cancer	0.0194	0.0925	CbGeAlD
Flucytosine—DNMT1—lymph node—colon cancer	0.0148	0.0709	CbGeAlD
Flucytosine—Azotaemia—Methotrexate—colon cancer	0.0104	0.0139	CcSEcCtD
Flucytosine—Deafness—Vincristine—colon cancer	0.00923	0.0124	CcSEcCtD
Flucytosine—Photosensitivity—Fluorouracil—colon cancer	0.00877	0.0117	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00804	0.0108	CcSEcCtD
Flucytosine—Cardiac arrest—Vincristine—colon cancer	0.00785	0.0105	CcSEcCtD
Flucytosine—Hearing impaired—Capecitabine—colon cancer	0.00779	0.0104	CcSEcCtD
Flucytosine—Ataxia—Vincristine—colon cancer	0.00776	0.0104	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.0077	0.0103	CcSEcCtD
Flucytosine—Cardiac arrest—Irinotecan—colon cancer	0.00765	0.0102	CcSEcCtD
Flucytosine—Cardiac arrest—Fluorouracil—colon cancer	0.00732	0.00981	CcSEcCtD
Flucytosine—Hypokalaemia—Irinotecan—colon cancer	0.00732	0.0098	CcSEcCtD
Flucytosine—Ataxia—Fluorouracil—colon cancer	0.00724	0.0097	CcSEcCtD
Flucytosine—Pancytopenia—Vincristine—colon cancer	0.00678	0.00908	CcSEcCtD
Flucytosine—Eosinophilia—Fluorouracil—colon cancer	0.00659	0.00883	CcSEcCtD
Flucytosine—Photosensitivity reaction—Vincristine—colon cancer	0.00651	0.00872	CcSEcCtD
Flucytosine—Pancytopenia—Fluorouracil—colon cancer	0.00632	0.00847	CcSEcCtD
Flucytosine—Neuropathy peripheral—Vincristine—colon cancer	0.00624	0.00835	CcSEcCtD
Flucytosine—Hepatic function abnormal—Capecitabine—colon cancer	0.00616	0.00825	CcSEcCtD
Flucytosine—Photosensitivity—Capecitabine—colon cancer	0.00613	0.00821	CcSEcCtD
Flucytosine—Renal failure—Irinotecan—colon cancer	0.00609	0.00816	CcSEcCtD
Flucytosine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00608	0.00814	CcSEcCtD
Flucytosine—Jaundice—Irinotecan—colon cancer	0.00604	0.00809	CcSEcCtD
Flucytosine—Deafness—Capecitabine—colon cancer	0.00602	0.00806	CcSEcCtD
Flucytosine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00582	0.00779	CcSEcCtD
Flucytosine—Hallucination—Vincristine—colon cancer	0.00568	0.00761	CcSEcCtD
Flucytosine—Haemoglobin—Irinotecan—colon cancer	0.00559	0.00749	CcSEcCtD
Flucytosine—Haemorrhage—Irinotecan—colon cancer	0.00556	0.00745	CcSEcCtD
Flucytosine—Agranulocytosis—Fluorouracil—colon cancer	0.00554	0.00742	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00538	0.00721	CcSEcCtD
Flucytosine—Haemoglobin—Fluorouracil—colon cancer	0.00536	0.00717	CcSEcCtD
Flucytosine—Haemorrhage—Fluorouracil—colon cancer	0.00533	0.00714	CcSEcCtD
Flucytosine—Aplastic anaemia—Methotrexate—colon cancer	0.00518	0.00694	CcSEcCtD
Flucytosine—Cardiac arrest—Capecitabine—colon cancer	0.00512	0.00685	CcSEcCtD
Flucytosine—Ataxia—Capecitabine—colon cancer	0.00506	0.00678	CcSEcCtD
Flucytosine—Hypokalaemia—Capecitabine—colon cancer	0.0049	0.00656	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00485	0.00649	CcSEcCtD
Flucytosine—Anaemia—Vincristine—colon cancer	0.0046	0.00615	CcSEcCtD
Flucytosine—Photosensitivity—Methotrexate—colon cancer	0.00456	0.00611	CcSEcCtD
Flucytosine—Anaemia—Irinotecan—colon cancer	0.00448	0.00599	CcSEcCtD
Flucytosine—Vertigo—Vincristine—colon cancer	0.00447	0.00598	CcSEcCtD
Flucytosine—Leukopenia—Vincristine—colon cancer	0.00445	0.00596	CcSEcCtD
Flucytosine—Pancytopenia—Capecitabine—colon cancer	0.00442	0.00592	CcSEcCtD
Flucytosine—Vertigo—Irinotecan—colon cancer	0.00435	0.00583	CcSEcCtD
Flucytosine—Leukopenia—Irinotecan—colon cancer	0.00434	0.0058	CcSEcCtD
Flucytosine—Convulsion—Vincristine—colon cancer	0.00431	0.00577	CcSEcCtD
Flucytosine—Anaemia—Fluorouracil—colon cancer	0.00429	0.00574	CcSEcCtD
Flucytosine—Photosensitivity reaction—Capecitabine—colon cancer	0.00425	0.00569	CcSEcCtD
Flucytosine—Leukopenia—Fluorouracil—colon cancer	0.00415	0.00556	CcSEcCtD
Flucytosine—Renal failure—Capecitabine—colon cancer	0.00408	0.00546	CcSEcCtD
Flucytosine—Neuropathy peripheral—Capecitabine—colon cancer	0.00407	0.00544	CcSEcCtD
Flucytosine—Jaundice—Capecitabine—colon cancer	0.00404	0.00541	CcSEcCtD
Flucytosine—Convulsion—Fluorouracil—colon cancer	0.00402	0.00538	CcSEcCtD
Flucytosine—Confusional state—Irinotecan—colon cancer	0.00399	0.00534	CcSEcCtD
Flucytosine—Thrombocytopenia—Vincristine—colon cancer	0.00397	0.00532	CcSEcCtD
Flucytosine—Chest pain—Fluorouracil—colon cancer	0.00395	0.00529	CcSEcCtD
Flucytosine—Agranulocytosis—Capecitabine—colon cancer	0.00387	0.00518	CcSEcCtD
Flucytosine—Thrombocytopenia—Irinotecan—colon cancer	0.00387	0.00518	CcSEcCtD
Flucytosine—Anorexia—Vincristine—colon cancer	0.00387	0.00518	CcSEcCtD
Flucytosine—Confusional state—Fluorouracil—colon cancer	0.00382	0.00511	CcSEcCtD
Flucytosine—Anorexia—Irinotecan—colon cancer	0.00377	0.00505	CcSEcCtD
Flucytosine—Ataxia—Methotrexate—colon cancer	0.00377	0.00504	CcSEcCtD
Flucytosine—Haemoglobin—Capecitabine—colon cancer	0.00374	0.00501	CcSEcCtD
Flucytosine—Hepatitis—Capecitabine—colon cancer	0.00372	0.00499	CcSEcCtD
Flucytosine—Haemorrhage—Capecitabine—colon cancer	0.00372	0.00499	CcSEcCtD
Flucytosine—Thrombocytopenia—Fluorouracil—colon cancer	0.00371	0.00496	CcSEcCtD
Flucytosine—Paraesthesia—Vincristine—colon cancer	0.00364	0.00488	CcSEcCtD
Flucytosine—Anorexia—Fluorouracil—colon cancer	0.00361	0.00483	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00361	0.00483	CcSEcCtD
Flucytosine—Paraesthesia—Irinotecan—colon cancer	0.00355	0.00475	CcSEcCtD
Flucytosine—Decreased appetite—Vincristine—colon cancer	0.00353	0.00472	CcSEcCtD
Flucytosine—Dyspnoea—Irinotecan—colon cancer	0.00352	0.00472	CcSEcCtD
Flucytosine—Fatigue—Vincristine—colon cancer	0.0035	0.00469	CcSEcCtD
Flucytosine—Decreased appetite—Irinotecan—colon cancer	0.00344	0.0046	CcSEcCtD
Flucytosine—Eosinophilia—Methotrexate—colon cancer	0.00343	0.00459	CcSEcCtD
Flucytosine—Fatigue—Irinotecan—colon cancer	0.00341	0.00456	CcSEcCtD
Flucytosine—Paraesthesia—Fluorouracil—colon cancer	0.0034	0.00455	CcSEcCtD
Flucytosine—Dyspnoea—Fluorouracil—colon cancer	0.00337	0.00452	CcSEcCtD
Flucytosine—Gastrointestinal pain—Vincristine—colon cancer	0.00332	0.00444	CcSEcCtD
Flucytosine—Decreased appetite—Fluorouracil—colon cancer	0.00329	0.00441	CcSEcCtD
Flucytosine—Pancytopenia—Methotrexate—colon cancer	0.00329	0.0044	CcSEcCtD
Flucytosine—Feeling abnormal—Irinotecan—colon cancer	0.00326	0.00436	CcSEcCtD
Flucytosine—Gastrointestinal pain—Irinotecan—colon cancer	0.00323	0.00433	CcSEcCtD
Flucytosine—Body temperature increased—Vincristine—colon cancer	0.00321	0.0043	CcSEcCtD
Flucytosine—Abdominal pain—Vincristine—colon cancer	0.00321	0.0043	CcSEcCtD
Flucytosine—Photosensitivity reaction—Methotrexate—colon cancer	0.00316	0.00423	CcSEcCtD
Flucytosine—Body temperature increased—Irinotecan—colon cancer	0.00312	0.00418	CcSEcCtD
Flucytosine—Abdominal pain—Irinotecan—colon cancer	0.00312	0.00418	CcSEcCtD
Flucytosine—Feeling abnormal—Fluorouracil—colon cancer	0.00312	0.00418	CcSEcCtD
Flucytosine—Renal failure—Methotrexate—colon cancer	0.00304	0.00406	CcSEcCtD
Flucytosine—Urticaria—Fluorouracil—colon cancer	0.00301	0.00403	CcSEcCtD
Flucytosine—Anaemia—Capecitabine—colon cancer	0.003	0.00401	CcSEcCtD
Flucytosine—Body temperature increased—Fluorouracil—colon cancer	0.00299	0.00401	CcSEcCtD
Flucytosine—Hypersensitivity—Vincristine—colon cancer	0.00299	0.004	CcSEcCtD
Flucytosine—Vertigo—Capecitabine—colon cancer	0.00291	0.0039	CcSEcCtD
Flucytosine—Hypersensitivity—Irinotecan—colon cancer	0.00291	0.0039	CcSEcCtD
Flucytosine—Asthenia—Vincristine—colon cancer	0.00291	0.0039	CcSEcCtD
Flucytosine—Leukopenia—Capecitabine—colon cancer	0.0029	0.00389	CcSEcCtD
Flucytosine—Agranulocytosis—Methotrexate—colon cancer	0.00288	0.00386	CcSEcCtD
Flucytosine—Asthenia—Irinotecan—colon cancer	0.00284	0.0038	CcSEcCtD
Flucytosine—Hypersensitivity—Fluorouracil—colon cancer	0.00279	0.00373	CcSEcCtD
Flucytosine—Haemoglobin—Methotrexate—colon cancer	0.00279	0.00373	CcSEcCtD
Flucytosine—Diarrhoea—Vincristine—colon cancer	0.00278	0.00372	CcSEcCtD
Flucytosine—Haemorrhage—Methotrexate—colon cancer	0.00277	0.00371	CcSEcCtD
Flucytosine—Hepatitis—Methotrexate—colon cancer	0.00277	0.00371	CcSEcCtD
Flucytosine—Chest pain—Capecitabine—colon cancer	0.00276	0.0037	CcSEcCtD
Flucytosine—Diarrhoea—Irinotecan—colon cancer	0.0027	0.00362	CcSEcCtD
Flucytosine—Dry mouth—Capecitabine—colon cancer	0.0027	0.00361	CcSEcCtD
Flucytosine—Pruritus—Fluorouracil—colon cancer	0.00268	0.00359	CcSEcCtD
Flucytosine—Confusional state—Capecitabine—colon cancer	0.00267	0.00357	CcSEcCtD
Flucytosine—Diarrhoea—Fluorouracil—colon cancer	0.00259	0.00347	CcSEcCtD
Flucytosine—Thrombocytopenia—Capecitabine—colon cancer	0.00259	0.00347	CcSEcCtD
Flucytosine—Vomiting—Vincristine—colon cancer	0.00258	0.00346	CcSEcCtD
Flucytosine—Rash—Vincristine—colon cancer	0.00256	0.00343	CcSEcCtD
Flucytosine—Dermatitis—Vincristine—colon cancer	0.00256	0.00342	CcSEcCtD
Flucytosine—Headache—Vincristine—colon cancer	0.00254	0.0034	CcSEcCtD
Flucytosine—Anorexia—Capecitabine—colon cancer	0.00252	0.00338	CcSEcCtD
Flucytosine—Vomiting—Irinotecan—colon cancer	0.00251	0.00337	CcSEcCtD
Flucytosine—Rash—Irinotecan—colon cancer	0.00249	0.00334	CcSEcCtD
Flucytosine—Dermatitis—Irinotecan—colon cancer	0.00249	0.00333	CcSEcCtD
Flucytosine—Headache—Irinotecan—colon cancer	0.00248	0.00332	CcSEcCtD
Flucytosine—Nausea—Vincristine—colon cancer	0.00241	0.00323	CcSEcCtD
Flucytosine—Vomiting—Fluorouracil—colon cancer	0.00241	0.00322	CcSEcCtD
Flucytosine—Rash—Fluorouracil—colon cancer	0.00239	0.0032	CcSEcCtD
Flucytosine—Dermatitis—Fluorouracil—colon cancer	0.00238	0.00319	CcSEcCtD
Flucytosine—Paraesthesia—Capecitabine—colon cancer	0.00238	0.00318	CcSEcCtD
Flucytosine—Headache—Fluorouracil—colon cancer	0.00237	0.00318	CcSEcCtD
Flucytosine—Dyspnoea—Capecitabine—colon cancer	0.00236	0.00316	CcSEcCtD
Flucytosine—Nausea—Irinotecan—colon cancer	0.00235	0.00314	CcSEcCtD
Flucytosine—Decreased appetite—Capecitabine—colon cancer	0.0023	0.00308	CcSEcCtD
Flucytosine—Fatigue—Capecitabine—colon cancer	0.00228	0.00305	CcSEcCtD
Flucytosine—Nausea—Fluorouracil—colon cancer	0.00225	0.00301	CcSEcCtD
Flucytosine—Anaemia—Methotrexate—colon cancer	0.00223	0.00299	CcSEcCtD
Flucytosine—Feeling abnormal—Capecitabine—colon cancer	0.00218	0.00292	CcSEcCtD
Flucytosine—Vertigo—Methotrexate—colon cancer	0.00217	0.0029	CcSEcCtD
Flucytosine—Gastrointestinal pain—Capecitabine—colon cancer	0.00216	0.0029	CcSEcCtD
Flucytosine—Leukopenia—Methotrexate—colon cancer	0.00216	0.00289	CcSEcCtD
Flucytosine—Urticaria—Capecitabine—colon cancer	0.0021	0.00281	CcSEcCtD
Flucytosine—Abdominal pain—Capecitabine—colon cancer	0.00209	0.0028	CcSEcCtD
Flucytosine—Body temperature increased—Capecitabine—colon cancer	0.00209	0.0028	CcSEcCtD
Flucytosine—Convulsion—Methotrexate—colon cancer	0.00209	0.0028	CcSEcCtD
Flucytosine—Chest pain—Methotrexate—colon cancer	0.00205	0.00275	CcSEcCtD
Flucytosine—Confusional state—Methotrexate—colon cancer	0.00199	0.00266	CcSEcCtD
Flucytosine—Hypersensitivity—Capecitabine—colon cancer	0.00195	0.00261	CcSEcCtD
Flucytosine—Thrombocytopenia—Methotrexate—colon cancer	0.00193	0.00258	CcSEcCtD
Flucytosine—Asthenia—Capecitabine—colon cancer	0.0019	0.00254	CcSEcCtD
Flucytosine—Anorexia—Methotrexate—colon cancer	0.00188	0.00251	CcSEcCtD
Flucytosine—Pruritus—Capecitabine—colon cancer	0.00187	0.00251	CcSEcCtD
Flucytosine—Diarrhoea—Capecitabine—colon cancer	0.00181	0.00242	CcSEcCtD
Flucytosine—Paraesthesia—Methotrexate—colon cancer	0.00177	0.00237	CcSEcCtD
Flucytosine—Dyspnoea—Methotrexate—colon cancer	0.00176	0.00235	CcSEcCtD
Flucytosine—Decreased appetite—Methotrexate—colon cancer	0.00171	0.00229	CcSEcCtD
Flucytosine—Fatigue—Methotrexate—colon cancer	0.0017	0.00227	CcSEcCtD
Flucytosine—Vomiting—Capecitabine—colon cancer	0.00168	0.00225	CcSEcCtD
Flucytosine—Rash—Capecitabine—colon cancer	0.00167	0.00223	CcSEcCtD
Flucytosine—Dermatitis—Capecitabine—colon cancer	0.00167	0.00223	CcSEcCtD
Flucytosine—Headache—Capecitabine—colon cancer	0.00166	0.00222	CcSEcCtD
Flucytosine—Feeling abnormal—Methotrexate—colon cancer	0.00162	0.00217	CcSEcCtD
Flucytosine—Gastrointestinal pain—Methotrexate—colon cancer	0.00161	0.00216	CcSEcCtD
Flucytosine—Nausea—Capecitabine—colon cancer	0.00157	0.0021	CcSEcCtD
Flucytosine—Urticaria—Methotrexate—colon cancer	0.00156	0.00209	CcSEcCtD
Flucytosine—Body temperature increased—Methotrexate—colon cancer	0.00156	0.00208	CcSEcCtD
Flucytosine—Abdominal pain—Methotrexate—colon cancer	0.00156	0.00208	CcSEcCtD
Flucytosine—Hypersensitivity—Methotrexate—colon cancer	0.00145	0.00194	CcSEcCtD
Flucytosine—Asthenia—Methotrexate—colon cancer	0.00141	0.00189	CcSEcCtD
Flucytosine—Pruritus—Methotrexate—colon cancer	0.00139	0.00187	CcSEcCtD
Flucytosine—Diarrhoea—Methotrexate—colon cancer	0.00135	0.0018	CcSEcCtD
Flucytosine—Vomiting—Methotrexate—colon cancer	0.00125	0.00168	CcSEcCtD
Flucytosine—Rash—Methotrexate—colon cancer	0.00124	0.00166	CcSEcCtD
Flucytosine—Dermatitis—Methotrexate—colon cancer	0.00124	0.00166	CcSEcCtD
Flucytosine—Headache—Methotrexate—colon cancer	0.00123	0.00165	CcSEcCtD
Flucytosine—Nausea—Methotrexate—colon cancer	0.00117	0.00157	CcSEcCtD
